Drawing for TIS

USPTO serial 77581266

TIS

Reviewed by CopyMark Law Group

Reg. 3789212Status 710
Filing date
Status date
Registration date
May 18, 2010
Examiner
KAUFMAN, LAURIE R
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with TIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Paul D. Bianco

PAUL D. BIANCO FLEIT GIBBONS GUTMAN BONGINI & BIANCO PL21355 E DIXIE HWYSUITE 115Miami, FL 33180

Goods and services

ClassDescriptionStatusFirst use
001Chemicals for use in industry and science; photographic chemicals; chemical preparations for use in agriculture, horticulture and forestry, namely, chemical preparations for the treatment of seeds; reagents for biological, biotechnological and chemical research; testing kits or analysis-kits for scientific purposes, predominantly made of chemical reagents; chemical reagents and kits predominantly composed of antibodies, lectins, peptides, aptamers, nucleic acids and nucleotides for scientific analytical purposesSECTION 8 - CANCELLED—
005Pharmaceutical preparations for affecting biological pathways, namely, for interfering or blocking cellular networks; diagnostic preparations for medical purposes; reagents for medical diagnostics, for the development of pharmaceutical preparations; testing kits or analysis-kits for medical purposes, predominantly made of chemical reagentsSECTION 8 - CANCELLED—
009Measuring, signalling and supervision instruments, namely, instruments for measuring protein network structures of cells and tissues; sample carriers and pipetting and dispensing devices, namely, pipettes used for the storage of samples; optical and microscopic instruments, namely, microscopes being laboratory equipment for research and industrial applications, in particular for use in the fields of biotechnology, pharmacy, medicine, diagnostics, chemistry and information technology; scientific apparatus and instruments, namely, microscopes for the analysis of cells and tissues, in particular for the development and manufacture of biotechnical, pharmaceutical and diagnostic products and processes; blank digital data media, namely, computer disks, CD-ROMs, and DVDs for the storage of images and computer programs; computer programs, namely, computer programs for the evaluation of experimental data; testing kits or analysis-kits for scientific purposes in connection with analysis instruments primarily comprising software for processing digital images of cells and tissuesSECTION 8 - CANCELLED—
035Arrangement and procurement of contractual agreements for third parties in connection with acquisition and selling of biotechnical, pharmaceutical and diagnostic products and processes, software and technical apparatus, in particular optical and microscopic instruments; Consultancy in the field of pharmacy, namely, business consulting services related to pharmaciesSECTION 8 - CANCELLED—
042Scientific research and development services in the fields of biotechnology, pharmacy, medicine, diagnostics, chemistry and information technology; development of biotechnical, pharmaceutical and diagnostic products and processes; development of computer software and technical apparatus, in particular optical and microscopic instruments, for third parties; development of processes in the field of functional genome research, molecular biological and cellular biological research, the identification, analysis and functional validation of genes and pharmaceutical active substance candidates, and in the field of the high-capacity searching of pharmaceutical active substancesSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 23, 2016C8..CANCELLED SEC. 8 (6-YR)—
May 18, 2010R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 9, 2010DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Mar 26, 2010AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 25, 2010IUCNNOTICE OF ALLOWANCE CANCELLED—
Mar 25, 2010D1BRTEAS DELETE 1(B) BASIS RECEIVED—
Mar 9, 2010NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 15, 2009NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 15, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 9, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 6, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 9, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 8, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 8, 2009ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Aug 20, 2009GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Aug 20, 2009GNSLLETTER OF SUSPENSION E-MAILED—
Aug 20, 2009CNSLSUSPENSION LETTER WRITTEN—
Jul 10, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 10, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 10, 2009CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 10, 2009ALIEASSIGNED TO LIE—
Jun 29, 2009TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 29, 2009TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 28, 2008GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 28, 2008GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 28, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 28, 2008DOCKASSIGNED TO EXAMINER—
Oct 3, 2008MPMKNOTICE OF PSEUDO MARK MAILED—
Oct 2, 2008NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance